StockData
Hyperfine, Inc. logo

Hyperfine, Inc. (HYPR) stock

HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3028% below fair value
$0.56−0.05 (-7.95%)

Close on Nov 17, 2026Market cap $59.56MP/E –Yield –

Hyperfine price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Hyperfine's price to sales ratio was 4.0× on Nov 11, 2026, against 7.7× a year earlier. Over the last 5 years it ranged from 3.8× to 51.8×, with a median of 7.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.0×−3.1
2025Dec 31, 20257.1×+2.3
2024Dec 31, 20244.8×−3.4
2023Dec 29, 20238.1×−14.5
2022Jan 31, 202222.7×−14.9
2021Dec 31, 202137.6×–

More Hyperfine figures

See a number that looks wrong?